SCHEMBL8968649

SCHEMBL8968649

O=[N+]([O-])c1cccc(-c2ccccc2)c1/C=C/N1CCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
TDP1 Q9NUW8 4/20 0.53
MAPT P10636 6/20 0.43
MAPK1 P28482 5/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KMT2A Q03164 5/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 1/20 0.40
APAF1 O14727 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.39
HTT P42858 3/20 0.38
S100A4 P26447 2/20 0.38
PTPRC P08575 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8968657 1.00 ALDH1A1 (0.53) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL14185148 0.87 ALDH1A1 (0.50) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL1126964 0.80 ALDH1A1 (0.48) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL1126961 0.80 ALDH1A1 (0.48) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL18842342 0.80 HSD17B10 (0.50) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL18816151 0.80 HSD17B10 (0.50) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL27955275 0.80 TDP1 (0.59) ALDH1A1TDP1MAPTNPC1RAB9A
SCHEMBL18816134 0.79 HSD17B10 (0.49) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL18816155 0.78 SIGMAR1 (0.45) ALDH1A1TDP1MAPTMAPK1NPC1
SCHEMBL18816133 0.77 ALDH1A1 (0.45) ALDH1A1TDP1MAPTMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5578609-A INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE, ANTITUMOR, TREATMENT OF ORGAN REJECTION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-11-26 US disclosed
US-5523408-A USED FOR TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION, GRAFT VERSUS HOST DISEASE, CHRONIC INFLAMMATORY DISEASES LIKE PSORIASIS, RHEUMATOID ARTHRITIS IN MAMMAL THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-06-04 US disclosed